Dr. Amal Fathy

/in /by

More than 15 years’ experience in the Pharmaceutical Industry,

 

My career journey is diverse, and I had the pleasure to experience different roles in the pharmaceutical industry starting from Sales moving to Sales Force Effectiveness and then shifting to Regulatory, where  I found my passion and kept progressing in my career development till reaching my current role as “Africa Science Affairs Head in Sanofi Consumer Healthcare” responsible for all the science functions (Regulatory – Medical – Quality & Pharmacovigilance) across Africa.

Dr. Mohamed Larbi Jelassi

/in /by

Mr. Franck Chauty

/in /by

Dr. Marlene Moonsamy

/in /by

Marlene Moonsamy is the Head of Regulatory Affairs for the African cluster at Astra Zeneca since April 2023. Her career in the Pharma industry spans 15 years, with 13 of them being in Regulatory Affairs.

 

Her qualifications include Bachelor of Pharmacy and Master of Science in Medicine (Pharmacotherapy) degrees, from the University of the Witwatersrand in Johannesburg, South Africa.

 

Her regulatory affairs journey started with Novartis in 2010. She has since acquired considerable leadership experience and expertise across the African markets with Johnson & Johnson, GSK Consumer and Pharma divisions, and finally Abbott Laboratories, before joining Astra Zeneca.

She has led sustainable change, developed high performing teams, and engaged externally to influence the regulatory environment, while garnering awards and accolades along the way.

Dr. Inas Chehimi

/in /by

Inas is a holder of Pharmacy diploma, and Master in EU and International Regulations and Healthcare Laws from Paris V University.

 

Inas has 20 years expertise in the European and Emergent markets regulations; she worked for various MNCs, and currently she is heading the Regulatory and Policy departments for MEA region in Novartis.

 

Her focus and interest are the Healthcare reforms and legislations, policy shaping with main objective to accelerate patient access to innovative medicines.

Inas chaired EFPIA and PhRMA association groups for 6 consecutive years, and actively participating as speaker in regional and international conferences.

Dr. Hebatallah Ibrahim Abdel-Salam

/in /by

She had a bachelor’s degree in pharmaceutical science.

She had a master’s degree in business administration in project management.

She is EDA representative as a member in the African Medicine Regulatory Harmonization (AMRH) Technical Committee on Regulatory Capacity Development (RCD-TC).

She is EDA representative as Chairperson of RCD-TC Subcommittee on Vaccines Regulatory

Oversight.

 

She was the former head of post approval changes department of biological products.

She was a member in the WHO team for assessing Covid-19 vaccines submitted for EUL.

She was a member in the team of updating registration guideline of biosimilar product in EGYPT.

 

She was a member in the team of issuing Procedures for Registration of Biological products through Reliance pathways.

Dr. Mona Mousa

/in /by

Dr. Mona Mousa has a bachelor’s degree of pharmaceutical Science from the

faculty of pharmacy Ain Shams University (2007).

 

She had been working in the Egyptian Drug Authority over the Past fourteen years,

Within managerial positions as head of Human Pharmaceuticals Regulatory and Technical Affairs

Administrations since 2019 till end of 2022.

 

Prior to that she had been working as a regulatory specialist in different departments at EDA,

Including Registration files review, Scientific and Technical Committee departments.

In addition to her experience as a pricing specialist and as an EDA Inspector.

Currently and since January 2023,

 

She is Regulatory Affairs Associate Director at Hikma – Egypt.

Dr. Amal Abdelkhalek Ibrahim

/in /by

Visionary leader bringing over 30 years of experience in RA field by establishing big product portfolio in Egypt and over 70 export Countries at Middle East and Gulf Countries, Africa, Europe, Asian and CIS Countries. Ensuring company products are on track with updated regulations

Successful achievements in registering the first two Egyptian Sterile Pharmaceutical Products at WHO Prequalification Program.

I consider each dossier as a case to be filed for a court, challenging the whole process till we won the case

I am a painter, and this gives me a touch of creative expression as problem solving and thinking outside the box with high attention to details

Dr. Haidy Ahmed

/in /by

After graduating from Faculty of Pharmacy-Ain Shams university, Haidy started her career at Egyptian Drug authority then joined Novartis CH as Head of regulatory for North Africa and Near East where she lead the regulatory function for English and French speaking Africa as well as LEVANT, in 2015 and as part of the Joint venture between Novartis and GSK Haidy joined GSK Consumer Healthcare leading the function within the same geography and now she is Director of regulatory affairs North, East and West Africa .She has a diversified experience across Africa and Near East in regulatory , pharmacovigilance and regulatory compliance while combining corporate and governmental legislative experience.

Ms. Susan Lin

/in /by

Susan Lin is a qualified pharmacist with a Bachelor of Pharmacy from Rhodes University with extensive experience in the healthcare industry.

 

Susan began her career in the public sector but later progressed to the Managed Care industry where she managed several portfolios. Her positions included the Executive Manager: Medicines Risk & Electronic Benefit Management and Senior Manager: Heath Policy Development.

 

Her interests have been focused on the development of strategies for enabling access to pharmaceuticals and medical technologies. She is a passionate advocate of sustainable solutions in promoting access to innovative medicines in South Africa.

 

Susan has recently joined PATH as the Senior Analyst: Public Health Advisor, where she provides advice on Africa’s health research and development, medical countermeasures manufacturing, regulatory harmonization, public health system, pandemic preparedness and health security to inform policy actions.